Document Detail

Diagnosis and management of cardiac sarcoidosis.
MedLine Citation:
PMID:  20109603     Owner:  NLM     Status:  MEDLINE    
Cardiac sarcoidosis is an underdiagnosed disease that may be present in as many as 25% of patients with systemic sarcoidosis. Although most commonly recognized in patients with other manifestations of sarcoidosis, it may occur in isolation and its presence is often not appreciated. Cardiac sarcoidosis may present as asymptomatic left ventricular dysfunction, congestive heart failure, atrioventricular block, atrial or ventricular arrhythmia and sudden death. Although untested in clinical trials, early use of high-dose steroid therapy may halt or reverse cardiac damage. This article reviews the clinical manifestations, diagnosis and treatment of sarcoidosis, with an emphasis on new imaging techniques and therapies.
Simon W Dubrey; Rodney H Falk
Related Documents :
3955583 - Postoperative evaluation of endomyocardial fibrosis.
22768193 - An analysis of the myocardial transcriptome in a mouse model of cardiac dysfunction wit...
21735533 - Lack of long-term clinical benefit of thrombus aspiration during primary percutaneous c...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Progress in cardiovascular diseases     Volume:  52     ISSN:  1873-1740     ISO Abbreviation:  Prog Cardiovasc Dis     Publication Date:    2010 Jan-Feb
Date Detail:
Created Date:  2010-01-29     Completed Date:  2010-02-22     Revised Date:  2013-05-02    
Medline Journal Info:
Nlm Unique ID:  0376442     Medline TA:  Prog Cardiovasc Dis     Country:  United States    
Other Details:
Languages:  eng     Pagination:  336-46     Citation Subset:  AIM; IM    
Hillingdon Hospital Uxbridge, United Kingdom.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Cardiomyopathies / complications,  diagnosis*,  therapy*
Cardiovascular Agents / therapeutic use
Diagnostic Imaging
Heart Transplantation
Immunosuppressive Agents / therapeutic use
Middle Aged
Myocardium / pathology
Predictive Value of Tests
Risk Factors
Sarcoidosis / complications,  diagnosis*,  therapy*
Treatment Outcome
Young Adult
Reg. No./Substance:
0/Cardiovascular Agents; 0/Immunosuppressive Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Anderson-Fabry disease and the heart.
Next Document:  Amyloid heart disease.